Tamiflu

Oseltamivir phosphate, marketed under the brand name Tamiflu, is an orally administered antiviral prodrug classified as a neuraminidase inhibitor. It represents a cornerstone in the strategic management of influenza virus infections, specifically targeting types A and B. Unlike broad-spectrum approaches, its mechanism is precisely engineered to inhibit a key enzyme the virus uses to propagate within the host. Since its approval, it has been a critical asset in both treatment and post-exposure prophylaxis, particularly during seasonal epidemics and pandemic preparedness plans.